Primarily niobium stent
US7101391B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 31, 2002 |
| Grant date | Sep 5, 2006 |
| Priority date | — |
| Expiry date | Jul 23, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61F2310/00598
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
In a process of fabricating a stent composed primarily of niobium alloyed with a trace amount of zirconium, tantalum, or titanium for hardening, the stent is annealed under vacuum in a substantially oxygen-free environment. The vacuum is preferably maintained at pressure less than 10−4 millibars, oxygen-content less than about 80 parts per million, and the annealing temperature exceeds 400° C. for at least one hour, and is preferably kept in a range from about 1100–1200° C. for several hours. This may be followed by applying a surface layer of oxide, such as iridium oxide, with a thickness of 299–300 nm to the stent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.